Cipher Pharmaceuticals Stock Current Asset
Cipher Pharmaceuticals fundamentals help investors to digest information that contributes to Cipher Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Cipher OTC Stock. The fundamental analysis module provides a way to measure Cipher Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cipher Pharmaceuticals otc stock.
Cipher |
Cipher Pharmaceuticals OTC Stock Current Asset Analysis
Cipher Pharmaceuticals' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, Cipher Pharmaceuticals has a Current Asset of 0.0. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
All Next | Launch Module |
Cipher Fundamentals
Return On Equity | 0.24 | ||||
Return On Asset | 0.15 | ||||
Profit Margin | 0.45 % | ||||
Operating Margin | 0.57 % | ||||
Current Valuation | 46.13 M | ||||
Shares Outstanding | 25.12 M | ||||
Shares Owned By Insiders | 44.12 % | ||||
Number Of Shares Shorted | 11.43 K | ||||
Price To Earning | 15.54 X | ||||
Price To Book | 1.63 X | ||||
Price To Sales | 3.28 X | ||||
Revenue | 21.94 M | ||||
Gross Profit | 18.26 M | ||||
EBITDA | 11.85 M | ||||
Net Income | 7.76 M | ||||
Cash And Equivalents | 24.19 M | ||||
Cash Per Share | 0.96 X | ||||
Total Debt | 507 K | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 2.51 X | ||||
Book Value Per Share | 1.77 X | ||||
Cash Flow From Operations | 13.81 M | ||||
Short Ratio | 0.97 X | ||||
Earnings Per Share | 0.36 X | ||||
Target Price | 5.59 | ||||
Number Of Employees | 26 | ||||
Beta | 1.03 | ||||
Market Capitalization | 64.32 M | ||||
Total Asset | 51.65 M | ||||
Z Score | 75.6 | ||||
Net Asset | 51.65 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Cipher OTC Stock
If you are still planning to invest in Cipher Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cipher Pharmaceuticals' history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |